Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA

Posted on Aug 24, 2018

Date on which the terms and conditions of the preferential rights issue were announced: 24 august 2018 Last day including right: 14 September 2018 Ex-date: 17 September 2018 Record Date: 18 September 2018 Date of approval: 14 September 2018 Maximum number of new shares: 12,000,000 Subscription price: 30 Will the rights be listed: yes This […]

Notice of Extraordinary General Meeting

Posted on Aug 24, 2018

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE […]

PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million

Posted on Aug 24, 2018

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE […]